The gold standard in cancer staging

November 03, 2009

Physicians and health care professionals around the world need a tool to facilitate the uniform description and reporting of cancer. Proper staging is essential to determine appropriate treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcomes. The newly published seventh edition of the AJCC Cancer Staging Manual, available in October 2009, brings together the relevant, evidence-based criteria for staging of cancer for 52 anatomic primary sites.

As knowledge of cancer biology expands, cancer staging must incorporate these advances. The American Joint Committee on Cancer (AJCC) Cancer Staging System is the preeminent paradigm used by physicians throughout the world to diagnose cancer and determine the extent of disease.

The AJCC Cancer Staging Manual is the "home base" product, which includes the rationale and rules for staging, the background explanation of the changes between the sixth and seventh editions, the definitions of tumor, lymph node involvement, and metastasis, stage groupings and histologic grade for 52 primary cancer sites. The successful and equally clinically relevant spin-off products are the AJCC Cancer Staging Handbook, which features all the staging information offered in the Manual in a pocket-size book, and the AJCC Cancer Staging Atlas, offering a highly visual representation with hundreds of additional illustrations. The AJCC e-Staging Tool, a web-based staging application designed to help clinicians stage patients in the clinical setting from desktop, laptop or handheld device, will be launched in December 2009.

The Annals of Oncology made this evaluation of the 6th edition: "At present there is no other book available which gives such a complete detailed account of stage definition, prognostic factors, prognosis and diagnostic procedures for stage definition in a comprehensive way as the AJCC Cancer Staging Manual... This book is a 'must' for all involved in cancer diagnosis and treatment."

The AJCC Cancer Staging Manual, Handbook, and Atlas, published by Springer, are prepared by the American Joint Committee on Cancer in collaboration with its member organizations, including the American Cancer Society, the National Cancer Institute and the American College of Physicians. These organizations work with the AJCC in the promotion of staging at the time of diagnosis in order to achieve better patient outcomes.
Stephen B. Edge, David R. Byrd, Carolyn C. Compton, April G. Fritz, Frederick L. Greene, Andrew Trotti (Eds.)

AJCC Cancer Staging Manual
2010. 7th ed. Softcover. $64.95, EUR 49.95, £44.99, ISBN 978-0-387-88440-0

AJCC Cancer Staging Handbook
2010. 7th ed. Softcover. $44.95, EUR 34.95, £31.99, ISBN 978-0-387-88442-4

AJCC Cancer Staging Atlas
2006. Softcover. $64.95, EUR 49.95, £44.99, ISBN 978-0-387-29014-0


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to